CervoMed (CRVO) Preferred Stock Liabilities (2022)
CervoMed's Preferred Stock Liabilities history spans 1 years, with the latest figure at $24.3 million for Q4 2022.
- For Q4 2022, Preferred Stock Liabilities changed N/A year-over-year to $24.3 million; the TTM value through Dec 2022 reached $24.3 million, changed N/A, while the annual FY2022 figure was $24.3 million, N/A changed from the prior year.
- Preferred Stock Liabilities for Q4 2022 was $24.3 million at CervoMed.
- Across five years, Preferred Stock Liabilities topped out at $24.3 million in Q4 2022 and bottomed at $24.3 million in Q4 2022.